pubmed-article:20525753 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C1882071 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C1442989 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
pubmed-article:20525753 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
pubmed-article:20525753 | pubmed:issue | 14 | lld:pubmed |
pubmed-article:20525753 | pubmed:dateCreated | 2010-7-16 | lld:pubmed |
pubmed-article:20525753 | pubmed:abstractText | Complete response to induction chemotherapy is observed in approximately 60% of patients with newly diagnosed non-M3 acute myelogenous leukemia (AML). However, no methods exist to predict with high accuracy at the individual patient level the response to standard AML induction therapy. | lld:pubmed |
pubmed-article:20525753 | pubmed:language | eng | lld:pubmed |
pubmed-article:20525753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20525753 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20525753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20525753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20525753 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20525753 | pubmed:month | Jul | lld:pubmed |
pubmed-article:20525753 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:MindenMark... | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:BoerE P JEP | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:FantlWendy... | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:KornblauSteve... | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:PuttaSantoshS | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:CesanoAlessan... | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:GaykoUrteU | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:RosenDavid... | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:CohenAileenA | lld:pubmed |
pubmed-article:20525753 | pubmed:author | pubmed-author:SpellmeyerDav... | lld:pubmed |
pubmed-article:20525753 | pubmed:copyrightInfo | Copyright 2010 AACR. | lld:pubmed |
pubmed-article:20525753 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20525753 | pubmed:day | 15 | lld:pubmed |
pubmed-article:20525753 | pubmed:volume | 16 | lld:pubmed |
pubmed-article:20525753 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20525753 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20525753 | pubmed:pagination | 3721-33 | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:meshHeading | pubmed-meshheading:20525753... | lld:pubmed |
pubmed-article:20525753 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20525753 | pubmed:articleTitle | Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapy. | lld:pubmed |
pubmed-article:20525753 | pubmed:affiliation | Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. | lld:pubmed |
pubmed-article:20525753 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:2322 | entrezgene:pubmed | pubmed-article:20525753 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20525753 | lld:entrezgene |